Home›Companies›Biotech & Pharma›Serotiny

Serotiny, Inc.

Updated Oct 27, 2026·Latest SEC filing Mar 20, 2023·Suggest an edit

About Serotiny

Serotiny is a private company based in San Francisco, California. It has reported $6,999,999 raised in two offerings on Form D since July 2018. Its chief executive is Colin Farlow.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 7, 2023Mar 20, 2023$4,000,000of $4.5M target2$2.0MDebt, Convertible promissory notesRule 506(b)Form D ↗
Jun 27, 2018Jul 11, 2018$2,999,999fully sold8$374KEquityRule 506(c)Form D ↗
Total, two offerings$6,999,999

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Serotiny's Form D filed Mar 20, 2023.

JF
Justin Farlow
Executive officer and director
CF
Colin Farlow
Chief Executive Officer and director
EM

Sources

  1. SECSerotiny, Inc. filing history